Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carmela Rodríguez
Observed names:
C. Rodríguez,
Carmela Rodriguez,
Rodríguez, Carmela
Institutions:
Complejo Hospitalario Universitario de Santiago,
Instituto de Investigación Sanitaria de Santiago,
Servicio Gallego de Salud
Observed institutions:
Complejo Hospitalario Universitario de Santiago,
Instituto de Investigación Sanitaria de Santiago,
Servicio Gallego de Salud,
Centro de Investigación Biomédica en Red de Cáncer
ORCID:
0009-0004-0936-6815
Observed ORCID:
0009-0004-0936-6815
OpenAlex ID:
A5090367371
Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients
2017
·
J. Vidal
, L. Muinelo
, et al.
·
Annals of Oncology
·
358
Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells
2020
·
Manuel Abreu
, Pablo Cabezas-Sainz
, et al.
·
Journal of Clinical Medicine
·
41
PDF
Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer
2016
·
Javier Mariscal
, Marta Alonso-Nocelo
, et al.
·
Scientific Reports
·
27
PDF
Red blood cell-tumor cell interactions promote tumor cell progression
2025
·
Thais Pereira-Veiga
, Celso Yáñez-Gómez
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
10
PDF
Gene expression analysis in circulating tumour cells to determine resistance to CDK4/6 inhibitors plus endocrine therapy in HR + /HER2- metastatic breast cancer patients
2025
·
Miriam González-Conde
, Celso Yáñez
, et al.
·
Journal of Translational Medicine
·
7
PDF
Abstract P5-01-09: Improving specificity and refining diagnostic accuracy of MRI in breast cancer with dedicated breast PET (dbPET)
2015
·
Ines Dominguez
, Michel Herranz
, et al.
·
Cancer Research
·
2
Circulating immune profiling reveals immune signatures associated with disease stage and outcome in endometrial cancer
2026
·
Raquel Piñeiro-Pérez
, Ana Vilar
, et al.
·
The Journal of Liquid Biopsy
Concordance analysis of non-invasive techniques for PIK3CA and ESR1 mutations in advanced HR+/HER2- breast cancer: the CANIPE study
2026
·
Clotilde Costa
, Ramón Manuel Lago-Lestón
, et al.
·
npj Precision Oncology
PDF
Abstract P5-02-17: Concordance Analysis of Non-Invasive determination techniques of PIK3CA and ESR1 mutations in patients with advanced luminal breast cancer. Study CANIPE
2025
·
Teresa Curiel
, Carmela Rodriguez
, et al.
·
Clinical Cancer Research
Circulating Immune Population As A Prognostic And Predictive Tool In Patients With Endometrial Cancer
2025
·
Raquel Piñeiro Perez
, Ana Vilar
, et al.
·
International Journal of Gynecological Cancer
Abstract P3-11-11: Dedicated breast PET (dbPET) a unique functional new tool to accurate quantify response to neoadjuvant therapy in breast cancer
2015
·
Michel Herranz
, Ines Dominguez
, et al.
·
Cancer Research
Prognostic factors in stage II colon cancer after radical resection.
2014
·
Nieves Martinez Lago
, Maria Vieito
, et al.
·
Journal of Clinical Oncology
Adjuvant chemoradiotherapy with infusional fluorouracil in high-risk adenocarcinoma of the stomach or gastroesophageal junction.
2014
·
Maria Vieito
, Nieves Martinez Lago
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
15
Citation count:
445
H-index:
5
I10-index:
4
Year
Topic
Type